Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 13NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2Brain Neoplasms 2Thymus Neoplasms 1Thymoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Meningioma 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

bicalutamide 23Radiotherapy 21Goserelin 21Docetaxel 19Flutamide 17Leuprolide 16Prednisone 11Radiotherapy, Conformal 10Gonadotropin-Releasing Hormone 10Radiotherapy, Intensity-Modulated 9Triptorelin Pamoate 8Buserelin 8Estramustine 7Androgen Antagonists 7Brachytherapy 6luprolide acetate gel depot 5enzalutamide 5Paclitaxel 5nilutamide 4darolutamide 4acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4Radiation 4Mitoxantrone 4Carboplatin 4orteronel 3apalutamide 3Selenium 3Orchiectomy 3Magnetic Resonance Spectroscopy 3Iodine-125 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Prostatic Neoplasms × Proton Therapy × Clear all
NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Proton Collaborative Group

Phase 2/3 Terminated
2 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡